Literature DB >> 18454272

Impact of the degree of liver resection on survival for patients with multiple liver metastases from colorectal cancer.

Kuniya Tanaka1, Hiroshi Shimada, Chizuru Matsumoto, Kenichi Matsuo, Kazuhisa Takeda, Yasuhiko Nagano, Shinji Togo.   

Abstract

BACKGROUND: Although the degree of hepatic resection has been found to be a key aspect of tumor stimulation, the differences in clinical outcome between a massive liver resection and a less extensive resection for multiple colorectal metastases have not been well studied. The purpose of this study was to clarify the impact of the extent of liver resection on survival outcome.
METHODS: Clinicopathologic data were available for 85 patients who were surgically treated for four or more liver metastases. Forty-nine patients who underwent a major hepatic resection were compared with patients who underwent minor hepatic resections (n = 36).
RESULTS: As the patients undergoing major resection were more likely to have multiple (p = 0.014) and large tumors (p = 0.021) compared to the minor-resection patients, their overall survival was worse (p = 0.046) and the disease-free rate tended to be poorer. By multivariate analysis of the cohorts, the only independent factor affecting survival was the number of liver tumors (< or =5 or > or =6; relative risk [RR] = 0.427; p = 0.014). When patients with six or more metastases were selected and analyzed, the overall survival of patients who had a major resection was significantly poorer than those who had minor resections (p = 0.028), although the clinical characteristics were comparable between the two groups.
CONCLUSION: Although the extent of hepatectomy was not an independent prognosticator, minor resections for multiple colorectal metastases may offer a long-term survival advantage compared to a major resection.

Entities:  

Mesh:

Year:  2008        PMID: 18454272     DOI: 10.1007/s00268-008-9610-0

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  47 in total

Review 1.  The molecular physiology of liver regeneration following partial hepatectomy.

Authors:  David Mangnall; Nigel C Bird; Ali W Majeed
Journal:  Liver Int       Date:  2003-04       Impact factor: 5.828

2.  Liver regeneration stimulates tumor metastases.

Authors:  Nadia Harun; Mehrdad Nikfarjam; Vijayaragavan Muralidharan; Christopher Christophi
Journal:  J Surg Res       Date:  2007-01-24       Impact factor: 2.192

3.  Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer.

Authors:  S Giacchetti; B Perpoint; R Zidani; N Le Bail; R Faggiuolo; C Focan; P Chollet; J F Llory; Y Letourneau; B Coudert; F Bertheaut-Cvitkovic; D Larregain-Fournier; A Le Rol; S Walter; R Adam; J L Misset; F Lévi
Journal:  J Clin Oncol       Date:  2000-01       Impact factor: 44.544

4.  Complete response of colorectal liver metastases after chemotherapy: does it mean cure?

Authors:  Stéphane Benoist; Antoine Brouquet; Christophe Penna; Catherine Julié; Mostafa El Hajjam; Sophie Chagnon; Emmanuel Mitry; Philippe Rougier; Bernard Nordlinger
Journal:  J Clin Oncol       Date:  2006-08-20       Impact factor: 44.544

5.  Outcome after hepatic resection versus combined resection and microwave ablation for multiple bilobar colorectal metastases to the liver.

Authors:  Kuniya Tanaka; Hiroshi Shimada; Yasuhiko Nagano; Itaru Endo; Hitoshi Sekido; Shinji Togo
Journal:  Surgery       Date:  2006-02       Impact factor: 3.982

6.  Two-stage hepatectomy: A planned strategy to treat irresectable liver tumors.

Authors:  R Adam; A Laurent; D Azoulay; D Castaing; H Bismuth
Journal:  Ann Surg       Date:  2000-12       Impact factor: 12.969

7.  Preoperative portal vein embolization for extended hepatectomy.

Authors:  Alan W Hemming; Alan I Reed; Richard J Howard; Shiro Fujita; Steven N Hochwald; James G Caridi; Irvin F Hawkins; Jean-Nicolas Vauthey
Journal:  Ann Surg       Date:  2003-05       Impact factor: 12.969

Review 8.  Hepatocyte growth factor/scatter factor, liver regeneration and cancer metastasis.

Authors:  W G Jiang; M B Hallett; M C Puntis
Journal:  Br J Surg       Date:  1993-11       Impact factor: 6.939

9.  Preliminary report of tumor metastasis during liver regeneration after hepatic resection in rats.

Authors:  Y Ikeda; T Matsumata; K Takenaka; O Sasaki; K Soejima; K Sugimachi
Journal:  Eur J Surg Oncol       Date:  1995-04       Impact factor: 4.424

10.  Portal vein embolization vs. portal vein ligation for induction of hypertrophy of the future liver remnant.

Authors:  Dieter C Broering; Christian Hillert; Gerrit Krupski; Lutz Fischer; Lars Mueller; Eike G Achilles; Jan Schulte am Esch; Xavier Rogiers
Journal:  J Gastrointest Surg       Date:  2002 Nov-Dec       Impact factor: 3.267

View more
  13 in total

Review 1.  Parenchymal-sparing liver surgery in patients with colorectal carcinoma liver metastases.

Authors:  Fernando A Alvarez; Rodrigo Sanchez Claria; Sebastian Oggero; Eduardo de Santibañes
Journal:  World J Gastrointest Surg       Date:  2016-06-27

Review 2.  Resection of colorectal liver metastases and extra-hepatic disease: a systematic review and proportional meta-analysis of survival outcomes.

Authors:  William J Hadden; Philip R de Reuver; Kai Brown; Anubhav Mittal; Jaswinder S Samra; Thomas J Hugh
Journal:  HPB (Oxford)       Date:  2016-02-01       Impact factor: 3.647

Review 3.  Anatomy of Hepatic Resectional Surgery.

Authors:  Michael C Lowe; Michael I D'Angelica
Journal:  Surg Clin North Am       Date:  2016-02-16       Impact factor: 2.741

4.  Parenchymal-sparing hepatectomies (PSH) for bilobar colorectal liver metastases are associated with a lower morbidity and similar oncological results: a propensity score matching analysis.

Authors:  Riccardo Memeo; Vito de Blasi; René Adam; Diane Goéré; Daniel Azoulay; Ahmet Ayav; Emilie Gregoire; Reza Kianmanesh; Francis Navarro; Antonio Sa Cunha; Patrick Pessaux
Journal:  HPB (Oxford)       Date:  2016-07-05       Impact factor: 3.647

5.  Parenchyma-preserving hepatic resection for colorectal liver metastases.

Authors:  Maximilian von Heesen; Jochen Schuld; Jens Sperling; Frank Grünhage; Frank Lammert; Sven Richter; Martin K Schilling; Otto Kollmar
Journal:  Langenbecks Arch Surg       Date:  2011-11-17       Impact factor: 3.445

Review 6.  Liver resection for advanced or aggressive colorectal cancer metastases in the era of effective chemotherapy: a review.

Authors:  Kuniya Tanaka; Yasushi Ichikawa; Itaru Endo
Journal:  Int J Clin Oncol       Date:  2011-07-26       Impact factor: 3.402

7.  Laparoscopic Parenchyma-sparing Liver Resection for Colorectal Metastases.

Authors:  Davit L Aghayan; Egidijus Pelanis; Åsmund Avdem Fretland; Airazat M Kazaryan; Mushegh A Sahakyan; Bård I Røsok; Leonid Barkhatov; Bjørn Atle Bjørnbeth; Ole Jakob Elle; Bjørn Edwin
Journal:  Radiol Oncol       Date:  2017-11-01       Impact factor: 2.991

8.  Proposal of Two Prognostic Models for the Prediction of 10-Year Survival after Liver Resection for Colorectal Metastases.

Authors:  Ulf Kulik; Mareike Plohmann-Meyer; Jill Gwiasda; Joline Kolb; Daniel Meyer; Alexander Kaltenborn; Frank Lehner; Jürgen Klempnauer; Harald Schrem
Journal:  HPB Surg       Date:  2018-10-21

9.  Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors.

Authors:  Gena P Kanas; Aliki Taylor; John N Primrose; Wendy J Langeberg; Michael A Kelsh; Fionna S Mowat; Dominik D Alexander; Michael A Choti; Graeme Poston
Journal:  Clin Epidemiol       Date:  2012-11-07       Impact factor: 4.790

10.  Parenchyma-sparing hepatectomy (PSH) versus non-PSH for bilobar liver metastases of colorectal cancer.

Authors:  Lidewij Spelt; Daniel Ansari; Max Swanling; Peter Holka; Roland Andersson
Journal:  Ann Gastroenterol       Date:  2017-10-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.